Joint Repair While Initiating Biologic Therapy in Rheumatoid Arthritis

被引：0
|
作者：
Brunet, Scott [1 ]
Manske, Sarah [1 ]
Engelke, Klaus [2 ]
Boyd, Steven [1 ]
Barnabe, Cheryl [1 ]
机构：
[1] Univ Calgary, Calgary, AB, Canada
[2] Erlangen Univ Hosp, Dept Med, Erlangen, Germany
来源：
JOURNAL OF RHEUMATOLOGY | 2019年 / 46卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
65
引用
收藏
页码：793 / 793
页数：1
相关论文
共 50 条
  • [31] Comorbidity and Cost Burden of Patients Prior to Initiating Abatacept or Infliximab As First Line Biologic Therapy for the Treatment of Rheumatoid Arthritis
    Darkow, Theodore
    Trivedi, Digisha
    Meissner, Brian
    Rosenblatt, Lisa
    Hebden, Tony
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S485 - S486
  • [32] Triple therapy with non-biologic DMARDs for rheumatoid arthritis or biologic therapy. Is it the same?
    Abud-Mendoza, Carlos
    Martinez-Martinez, Marco U.
    REUMATOLOGIA CLINICA, 2014, 10 (05): : 345 - 346
  • [33] Newly developed cardiovascular risk factors in rheumatoid arthritis patients initiating biologic treatment
    Zareba, Wojciech
    Krawiec, Piotr
    Banaszkiewicz, Malgorzata
    Batko, Krzysztof
    Golab, Aleksandra
    Plicner, Dariusz
    Zuber, Zbigniew
    Batko, Bogdan
    REUMATOLOGIA, 2023, 61 (06): : 424 - 431
  • [34] Comparing biologic persistence and healthcare costs in rheumatoid arthritis patients initiating subcutaneous biologics
    Nadkarni, Anagha
    McMorrow, Donna
    Fowler, Robert
    Smith, David
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2017, 6 (08) : 659 - 669
  • [35] Radius 1-comparison of disease characteristics of patients with rheumatoid arthritis initiating biologic therapy for the first time versus other DMARD therapy
    Gibofsky, A
    Cush, J
    Schiff, MH
    Keystone, EC
    Markenson, JA
    Weaver, A
    Freundlich, B
    Whitmore, J
    Leff, J
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 410 - 410
  • [36] THE SIGNIFICANCE OF SERUM IGA IN RHEUMATOID ARTHRITIS IN THE ERA OF BIOLOGIC THERAPY
    Nakashima, A.
    Takeshi, Z.
    Ogane, K.
    Yamada, K.
    Kawano, M.
    Yachie, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 404 - 404
  • [37] Combination therapy with biologic agents in rheumatoid arthritis: Perils and promise
    Kremer, JM
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : 1548 - 1551
  • [38] Use of Biologic Therapy As Monotherapy in Patients with Rheumatoid Arthritis.
    Gomez-Centeno, Antonio
    Martinez, Olga
    Javier Ballina, Francisco
    Manuel Rodriguez, Jose
    Grana, Jenaro
    Brito, Manuel
    Sampedro, Juana
    Iglesias, Gerardo
    Delgado, Concepcion
    Monteagudo, Indalecio
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1082 - S1083
  • [39] What are the risks of biologic therapy in rheumatoid arthritis? An update on safety
    Weisman, MH
    JOURNAL OF RHEUMATOLOGY, 2002, 29 : 33 - 38
  • [40] Surgery of the Wrist and of the Hand in Rheumatoid Arthritis at the Time of Biologic Therapy
    Merle, Michel
    E-MEMOIRES DE L ACADEMIE NATIONALE DE CHIRURGIE, 2015, 14 (02): : 36 - 44
12345